Abstract: In this article, we present a design concept, in which a monolithic soft body is incorporated with a vibration-driven mechanism, called Leafbot. We first report a morphological design of the ...

Currently, Medicare has to wait seven years after a traditional drug gets approved by the U.S. Food and Drug Administration (FDA) before it’s eligible for Medicare price negotiations. Traditional ...

Approval of New Oral Anticoagulant Drugs The continued quest for an 'ideal anticoagulant' led to the US FDA's recent approval of dabigatran etexilate, a prodrug for dabigatran (Pradaxa ...

Edith Nutescu, Pharm.D., FCCP Disclosures Am J Health Syst Pharm. 2012;69 (13):1113-1126.

The creative team and stars of ‘Superman’ (from left to right) David Corenswet (Clark Kent/Superman), Director James Gunn, DC Studios Co-chairman & Co-CEO Peter Safran, and Rachel Brosnahan (Lois Lane ...

Extended anticoagulation using reduced-dose apixaban was found to be noninferior to using full-dose apixaban in preventing recurrent venous thromboembolism (VTE) in patients who had active cancer ...

SM Prime Holdings Inc. (SMPH) reported a 15-percent increase in foot traffic at its Mall of Asia (MOA) Complex in the first quarter of 2025, with visits reaching 34.5 million. SMPH, in a disclosure to ...

Between now and 2028, Pfizer will lose patent exclusivity for Inlyta, Xeljanz, Prevnar 13, Eliquis, Ibrance, Mektovi, Xtandi, and Vyndaqel. Five of those eight products were blockbusters last year.

With the end of the pandemic, sales of Pfizer’s PFE COVID products, Comirnaty and Paxlovid, have declined. Though COVID revenues are declining, Pfizer’s non-COVID operational revenues improved ...

Eliquis (apixaban) is an anticoagulant used to lower the chance of stroke in people with atrial fibrillation (AFib), a common type of irregular heartbeat (arrhythmia). Most Medicare prescription ...